About Us

Our strength as a leadership team comes from decades of previous experience and collaboration in both academic and industry environments.

We know that our goal is elusive and that the work we do is not easy, but we are focused and determined to create better therapeutics. We are not alone. Our mission is supported by an outstanding Board of Directors and collaboration with industry-leading partners.

Leadership Team

David

David

Meininger, PhD, MBA

Co-founder & Chief Executive Officer

Diana

Diana

Hausman, MD

Chief Medical Officer

Chris

Chris

Mehlin, PhD

Co-founder & Chief Scientific Officer

Eric

Eric

Gruff, PhD, MBA

Chief Development Officer

Jane

Jane

Carter

Director of Operations

Ashok

Ashok

Bandaranayake, PhD

Co-founder & Vice President, Immuno-Oncology

Colin E.

Colin E.

Correnti, PhD

Co-Founder & Vice President, Protein Therapeutics

Board of Directors

Roger

Roger

Ulrich, PhD

Chairman

Edward 

Edward 

van Wezel

BioGeneration Ventures

Daniel

Daniel

O’Connell, MD, PhD

Bristol Myers Squibb

David

David

Meininger, PhD, MBA

Link Immunotherapeutics, Inc.

Investors